Abstract

Identification of signaling pathways that maintain and promote adult pancreatic islet functions will accelerate our understanding of organogenesis and improve strategies for treating diseases like diabetes mellitus. Previous work has implicated transforming growth factor-β (TGF-β) signaling as an important regulator of pancreatic islet development, but has not established whether this signaling pathway is required for essential islet functions in the adult pancreas. Here we describe a conditional system for expressing Smad7, a potent inhibitor of TGF-β signaling, to identify distinct roles for this pathway in adult and embryonic β cells. Smad7 expression in Pdx1 + embryonic pancreas cells resulted in striking embryonic β cell hypoplasia and neonatal lethality. Conditional expression of Smad7 in adult Pdx1 + cells reduced detectable β cell expression of MafA, menin, and other factors that regulate β cell function. Reduced pancreatic insulin content and hypoinsulinemia produced overt diabetes that was fully reversed upon resumption of islet TGF-β signaling. Thus, our studies reveal that TGF-β signaling is crucial for establishing and maintaining defining features of mature pancreatic β cells.

Highlights

  • A major goal in studies of pancreatic islet development and diabetes mellitus is the identification of signaling pathways that maintain adult pancreatic islet functions

  • Similar to the effect of Smad7 misexpression, loss of growth/differentiation factor 11 (Gdf11) reduced MafA expression in b cells. These data suggest that transforming growth factor-b (TGF-b) signaling is essential for expression of characteristic b cell functions in both the embryonic and adult pancreas. These studies reveal a requirement for TGF-b signaling in maintaining pancreatic islet functions

  • One principal finding from this study is that Smad7 expression in adult pancreatic b cells leads to reduced expression of insulin and nuclear factors like MafA, menin, and p27Kip1

Read more

Summary

Introduction

A major goal in studies of pancreatic islet development and diabetes mellitus is the identification of signaling pathways that maintain adult pancreatic islet functions. Redundant TGF-b signaling activities and pleiotropism from germline mutations producing postnatal lethality have limited conclusions about the role of this signaling pathway in adult islets [3,4,5] It remains unclear if TGF-b signaling disruption may impair islet function, leading to pathogenesis of diseases like diabetes. The developing and adult pancreas expresses multiple TGF-b ligands, like TGF-b1, activins, and bone morphogenetic proteins (BMPs), which are known to bind heteromeric receptor complexes comprised of membrane-associated type I and type II receptor kinases. Ligand activation of these receptors triggers phosphorylation of intracellular proteins called receptor-regulated Smads (RSmads), which form heteromeric complexes with Smad 4. The inhibitory Smads, Smad and Smad, block TGF-b signaling by blocking R-Smad phosphorylation and may target TGF-b receptors for degradation [10,11,12,13]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call